- Home
- ADXN vs NURO Comparison
ADXN vs NURO Comparison
Compare ADXN & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- NURO
- Stock Information
- Founded
- ADXN 2002
- NURO 1996
- Country
- ADXN Switzerland
- NURO United States
- Employees
- ADXN N/A
- NURO N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- NURO Medical/Dental Instruments
- Sector
- ADXN Health Care
- NURO Health Care
- Exchange
- ADXN Nasdaq
- NURO Nasdaq
- Market Cap
- ADXN 8.0M
- NURO 8.2M
- IPO Year
- ADXN N/A
- NURO N/A
- Fundamental
- Price
- ADXN $7.52
- NURO $4.39
- Analyst Decision
- ADXN Strong Buy
- NURO
- Analyst Count
- ADXN 1
- NURO 0
- Target Price
- ADXN $30.00
- NURO N/A
- AVG Volume (30 Days)
- ADXN 11.6K
- NURO 15.9K
- Earning Date
- ADXN 03-24-2025
- NURO 03-04-2025
- Dividend Yield
- ADXN N/A
- NURO N/A
- EPS Growth
- ADXN N/A
- NURO N/A
- EPS
- ADXN 0.06
- NURO N/A
- Revenue
- ADXN $701,260.00
- NURO $3,767,764.00
- Revenue This Year
- ADXN N/A
- NURO N/A
- Revenue Next Year
- ADXN N/A
- NURO N/A
- P/E Ratio
- ADXN $0.96
- NURO N/A
- Revenue Growth
- ADXN N/A
- NURO N/A
- 52 Week Low
- ADXN $6.67
- NURO $2.66
- 52 Week High
- ADXN $27.90
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- ADXN 48.90
- NURO 63.96
- Support Level
- ADXN $6.67
- NURO $4.35
- Resistance Level
- ADXN $7.80
- NURO $4.45
- Average True Range (ATR)
- ADXN 0.39
- NURO 0.06
- MACD
- ADXN 0.04
- NURO -0.00
- Stochastic Oscillator
- ADXN 62.04
- NURO 60.39
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.